1-42746620-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_022356.4(P3H1):​c.*77C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0454 in 1,253,560 control chromosomes in the GnomAD database, including 1,611 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.059 ( 360 hom., cov: 33)
Exomes 𝑓: 0.044 ( 1251 hom. )

Consequence

P3H1
NM_022356.4 3_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -1.25

Publications

9 publications found
Variant links:
Genes affected
P3H1 (HGNC:19316): (prolyl 3-hydroxylase 1) This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
P3H1 Gene-Disease associations (from GenCC):
  • osteogenesis imperfecta type 8
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-42746620-G-A is Benign according to our data. Variant chr1-42746620-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 873600.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=2}.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
P3H1NM_022356.4 linkc.*77C>T 3_prime_UTR_variant Exon 15 of 15 ENST00000296388.10 NP_071751.3 Q32P28-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
P3H1ENST00000296388.10 linkc.*77C>T 3_prime_UTR_variant Exon 15 of 15 1 NM_022356.4 ENSP00000296388.5 Q32P28-1

Frequencies

GnomAD3 genomes
AF:
0.0587
AC:
8928
AN:
152082
Hom.:
358
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.0844
Gnomad AMR
AF:
0.0469
Gnomad ASJ
AF:
0.0605
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0557
Gnomad FIN
AF:
0.0308
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0409
Gnomad OTH
AF:
0.0686
GnomAD4 exome
AF:
0.0436
AC:
47990
AN:
1101360
Hom.:
1251
Cov.:
15
AF XY:
0.0438
AC XY:
24331
AN XY:
555120
show subpopulations
African (AFR)
AF:
0.116
AC:
2965
AN:
25644
American (AMR)
AF:
0.0412
AC:
1447
AN:
35148
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
1409
AN:
23156
East Asian (EAS)
AF:
0.000641
AC:
22
AN:
34348
South Asian (SAS)
AF:
0.0545
AC:
3990
AN:
73174
European-Finnish (FIN)
AF:
0.0280
AC:
1354
AN:
48398
Middle Eastern (MID)
AF:
0.0708
AC:
272
AN:
3842
European-Non Finnish (NFE)
AF:
0.0423
AC:
34241
AN:
809686
Other (OTH)
AF:
0.0477
AC:
2290
AN:
47964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
2395
4789
7184
9578
11973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1184
2368
3552
4736
5920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0588
AC:
8944
AN:
152200
Hom.:
360
Cov.:
33
AF XY:
0.0578
AC XY:
4303
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.106
AC:
4400
AN:
41520
American (AMR)
AF:
0.0468
AC:
716
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0605
AC:
210
AN:
3472
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5168
South Asian (SAS)
AF:
0.0558
AC:
269
AN:
4822
European-Finnish (FIN)
AF:
0.0308
AC:
327
AN:
10612
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0408
AC:
2777
AN:
68000
Other (OTH)
AF:
0.0678
AC:
143
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
447
894
1341
1788
2235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0498
Hom.:
98
Bravo
AF:
0.0634
Asia WGS
AF:
0.0270
AC:
93
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Osteogenesis Imperfecta, Recessive Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Osteogenesis imperfecta type 8 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
Jun 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.6
DANN
Benign
0.58
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13871; hg19: chr1-43212291; API